![Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia | BMC Cancer | Full Text Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-016-2841-9/MediaObjects/12885_2016_2841_Fig3_HTML.gif)
Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia | BMC Cancer | Full Text
![Web calculator showing survival estimates for clinical example 1, 12... | Download Scientific Diagram Web calculator showing survival estimates for clinical example 1, 12... | Download Scientific Diagram](https://www.researchgate.net/publication/317607599/figure/fig3/AS:614313379233792@1523475131063/Web-calculator-showing-survival-estimates-for-clinical-example-1-12-months-after.png)
Web calculator showing survival estimates for clinical example 1, 12... | Download Scientific Diagram
![Cancers | Free Full-Text | Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer Cancers | Free Full-Text | Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer](https://www.mdpi.com/cancers/cancers-12-02103/article_deploy/html/images/cancers-12-02103-g003.png)
Cancers | Free Full-Text | Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/34b2410d-db54-46e1-ac1d-1d1894292938/gr1_lrg.gif)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/aebe7284-f489-4fa5-a13d-db5ed5bcba73/gr2_lrg.jpg)